SLC52A3 and hyperlipidemia: We demonstrated for the first time that Rfvt3 contributes to placental riboflavin transport, and disruption of Slc52a3 caused neonatal lethality with hyperlipidemia and hypoglycemia owing to riboflavin deficiency.